Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 1/2019

Open Access 01-01-2019 | Genetics

Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation?

Authors: Maruška Čuš, Veljko Vlaisavljević, Katja Repnik, Uroš Potočnik, Borut Kovačič

Published in: Journal of Assisted Reproduction and Genetics | Issue 1/2019

Login to get access

Abstract

Purpose

The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in selected genes, responsible for hormonal regulation of folliculogenesis, are associated with response to controlled ovarian hyperstimulation (COH) and clinical characteristics of women enrolled in in vitro fertilization (IVF) programs.

Methods

In a cross-sectional study, 60 (IVF) patients underwent COH by using gonadotropin-releasing hormone (GnRH) antagonist and recombinant follicle-stimulating hormone (rFSH) protocol. Patients were classified into three groups: poor-responders (according to Bologna criteria), normo-responders (≤ 15 oocytes), and hyper-responders (> 15 oocytes). Genotyping of SNPs AMH rs10407022, AMHR rs3741664, FSHR rs1394205 and rs6166, and ESR1 rs2234693 was performed using high-resolution melting analysis (HRMA). Basal FSH (bFSH), estradiol (E2), and anti-Müllerian hormone (AMH) were measured by enzyme-linked immunosorbent assay (ELISA).

Results

Patients with GG genotype of FSHR rs1394205 had significantly lower AMH level (P = 0.016) and required higher rFSH dose per oocyte compared to women with AA or AG genotype (P = 0.036). We also found higher frequency of GG genotype of FSHR rs1394205 in poor- (76.5%) than in hyper-responders (37.5%, P = 0.002). Patients with AA genotype of FSHR rs6166 had higher level of measured bFSH compared to those with AG or GG genotypes (P = 0.043). Women with GG genotype of AMHR rs3741664 required higher rFSH dose in comparison with patients carrying genotypes AA or AG (P = 0.028).

Conclusions

The GG genotype at position rs1394205 is associated with poor ovarian response to COH. Patients with this genotype may require higher doses of rFSH for ovulation induction.
Literature
1.
Altmäe S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17:813–28.CrossRefPubMed
2.
3.
4.
Minegishi T, Nakamura K, Takakura Y, Ibuki Y, Igarashi M. Cloning and sequencing of human FSH receptor cDNA. Biochem Biophys Res Commun. 1991;175:1125–30.CrossRefPubMed
5.
Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction. 2013;146:235–48.CrossRef
6.
Mayorga MP, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365–9.
7.
Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Human Reprod. 2002;8:893–9.CrossRef
8.
9.
Gashi Z, Elezaj S, Zeqiraj A, Grabanica D, Gashi F. Follicle-stimulating hormone receptor gene polymorphism in Albanian women. Arch Med Sci Civil Dis. 2016;1:87–97.
10.
Bonyadi K, Damavandi E, Choobineh H, Kabuli M, Agha-Hosseini M, Ghadami M. Association of FSH receptor promoter’s polymorphisms with IVF-failure in Iranian women. Int J Reprod Contracept Obstet Gynecol. 2017;6(9):3760–4.CrossRef
11.
Jun JK, Yoon JS, Ku SY. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Human Genet. 2006;51:665–70.CrossRef
12.
Mohiyiddeen L, Newman WG, Cerra C, McBurney H, Mulugeta B, Roberts SA, et al. A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril. 2013;99:149–55.CrossRefPubMed
13.
Wunsch A, Ahda Y, Banaz-Yas F, Sonntag B, Nieschlag E, Simoni M, et al. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle stimulating hormone receptor. Fertil Steril. 2005;84:446–53.CrossRefPubMed
14.
Goldenberg RL, Vaitukaitis JL, Ross GT. Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology. 1972;90(6):1492–8.CrossRefPubMed
15.
Georgiou I, Konstantelli M, Syrrou M, Messinis IE, Lolis DE. Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum Reprod. 1997;12(7):1430–3.CrossRefPubMed
16.
Sundarrajan C, Liao W, Roy AC, Ng SC. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol Hum Reprod. 1999;5:797–802.CrossRefPubMed
17.
Altmäe S, Haller K, Peters M, Hovatta O, Stavreus-Evers A, Karro H, et al. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod. 2007;13:521–6.CrossRefPubMed
18.
Ayvaz OU, Ekmekçi A, Baltaci V, Onen HI, Unsal E. Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility. J Assist Reprod Genet. 2009;26(9–10):503–10.CrossRefPubMedPubMedCentral
19.
He M, Shu J, Huang X, Tang H. Association between estrogen receptor gene (ESR1) PvuII (T/C) and XbaI (A/G) polymorphisms and premature ovarian failure risk: evidence from a meta-analysis. J Assist Reprod Genet. 2015;32:297–304.CrossRefPubMed
20.
Rigon C, Andrisani A, Forzan M, D'Antona D, Bruson A, Cosmi E, et al. Association study of AMH and AMHRII polymorphisms with unexplained infertility. Fertil Steril. 2010;94(4):1244–8.CrossRefPubMed
21.
Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77–83.CrossRefPubMed
22.
Visser JA, Themmen APN. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005;234:81–6.CrossRefPubMed
23.
Durlinger AL, Gruijters MJG, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143(3):1076–84.CrossRefPubMed
24.
Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JTJ, Grootegoed A, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999;140(12):5789–96.CrossRefPubMed
25.
Durlinger AL, Gruijters MJG, Kramer P, Karels B, Matzuk MM, Rose UM, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142(11):4891–9.CrossRefPubMed
26.
Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong S, de Jong F, et al. Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase oestradiol levels in normo-ovulatory women. Hum Reprod. 2007;22(6):1547–54.CrossRefPubMed
27.
Simoni M, Livio C. Mechanisms in endocrinology: genetics of FSH action - a 2014-and-beyond view. Eur J Endocrinol. 2014;170:91–107.CrossRef
28.
Falconer H, Andersson E, Aanesen A, Fried G. Follicle stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet Gynecol Scand. 2005;84:806–11.CrossRefPubMed
29.
Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006;23:177–84.CrossRefPubMedPubMedCentral
30.
Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metabol. 2011;103:388–93.CrossRef
31.
Huang X, Li L, Hong L, et al. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation. Clin Endocrinol. 2015;82:77–83.
32.
Sheikhha MH, Eftekhar M, Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Human Reprod Sci. 2011;4:86–90.CrossRef
33.
34.
35.
Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, et al. Mutation of the follicle-stimulating hormone receptor gene 5′-untranslated region associated with female hypertension. Hypertension. 2006;48:512–8.CrossRefPubMed
36.
Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV, et al. Follicle-stimulating hormone receptor polymorphism (g-29a) is associated with altered level of receptor expression in granulosa cells. J Clin Endocrinol Metab. 2011;96(9):2805–12.CrossRefPubMed
37.
Cai J, Lou H, Dong M, Lu XE, Zhu YM, Gao HJ, et al. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Fertil Steril. 2007;87:1350–65.CrossRefPubMed
38.
Gerasimova T, Thanasoula MN, Zattas D, Seli E, Sakkas D, Lalioti MD. Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH. J Clin Endocrinol Metab. 2010;95:529–36.CrossRefPubMedPubMedCentral
39.
40.
de Mattos CS, Trevisan CM, Peluso C, Adami F, Cordts EB, Christofolini DM, et al. ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women. J Ovarian Res. 2014;7:114.CrossRefPubMedPubMedCentral
41.
de Castro F, Morán FJ, Montoro L, Galán JJ, Pérez- Hernández D, ES-C P, et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenet Genom. 2004;14:285–93.CrossRef
42.
Behre HM, Hermann M, Greb R, Mempel A, Sonntag B, Kiesel L, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genom. 2005;15:451–6.CrossRef
43.
Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89:6310–5.CrossRefPubMed
44.
Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod BioMed Online. 2009;18(4):509–15.CrossRefPubMed
45.
Kerkelä E, Skottman H, Friden B, Bjuresten K, Kere J, Hovatta O. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertil Steril. 2007;87:603–6.CrossRefPubMed
46.
Arce JC, Andersen AN, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, et al. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antiMüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014;102(6):1633–1640.e5.CrossRefPubMed
47.
Hayashi M, Yamashita Y, Hayashi A, Yoshida Y, Kawabe S, Hayashi M, et al. Expression and epigenetic change of the AR and FSHR genes in the granulosa cells of endometriosis patients. Genet Epigenet. 2012;1(4):1–8.
48.
Yu B, Russanova VR, Gravina S, Hartley S, Mullikin JC, Ignezweski A, et al. DNA methylome and transcriptome sequencing in human ovarian granulosa cells links age-related changes in gene expression to gene body methylation and 3′-end GC density. Oncotarget. 2015;6(6):3627–43.PubMedPubMedCentral
Metadata
Title
Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation?
Authors
Maruška Čuš
Veljko Vlaisavljević
Katja Repnik
Uroš Potočnik
Borut Kovačič
Publication date
01-01-2019
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 1/2019
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1357-4

Other articles of this Issue 1/2019

Journal of Assisted Reproduction and Genetics 1/2019 Go to the issue

Genetics

Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization

Letter to the Editor

Is it realistic to consider vitamin D as a follicular and serum marker of human oocyte quality?

Genetics

Gene variants identified by whole-exome sequencing in 33 French women with premature ovarian insufficiency

Genetics

Minichromosome maintenance complex component 8 and 9 gene expression in the menstrual cycle and unexplained primary ovarian insufficiency

Assisted Reproduction Technologies

Risk of prematurity and infant morbidity and mortality by maternal fertility status and plurality

Genetics

A successful treatment with 5 methyltetrahydrofolate of a 677 TT MTHFR woman suffering premature ovarian insufficiency post a NHL (non-Hodgkin’s lymphoma) and RPL (repeat pregnancy losses)